Skip to main content

Table 1 Patients information

From: 2B4 costimulatory domain enhancing cytotoxic ability of anti-CD5 chimeric antigen receptor engineered natural killer cells against T cell malignancies

Patient ID Sex Age Disease CD5(%) SFI
P1 M 74 MCL 96.5 140.05
P2 F 65 CLL 78.3 207.71
P3 F 56 CLL 95.3 323.27
P4 M 73 CD5+ B-CLPDs unclassified 71.6 90.44
P5 F 67 CLL 96.5 109.07
P6 M 51 T-ALL 88.9 100.62
P7 F 58 T-ALL 88.4 83.36
  1. F female, M male, MCL mantle cell lymphoma, CLL chronic lymphocytic leukemia, CD5+ B-CLPDs unclassified unclassified CD5+ B-cell chronic lymphoproliferative disorders, T-ALL T-cell acute lymphoblastic leukemia